Continued execution across Ampligen® (rintatolimod) clinical development programs in areas with critical unmet needs, especially in the high-value pancreatic cancer…
Chetan Pujara, Ph.D Chief Research & Development Officer, SpyGlass Pharma Dr. Pujara brings extensive industry experience to guide late-stage development…
NEW YORK and PARIS, March 26, 2025 /PRNewswire/ -- Rarecells Inc., a pioneering company in liquid biopsy technology, is pleased…
"Trailblazing Physician and Advocate Receives U.S. Congressional Award for Advancing Healthcare Access and Community Service Across Central Florida and Beyond"…
SOUTH SAN FRANCISCO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical…
Montreal, Quebec--(Newsfile Corp. - March 26, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the…
CLEVELAND, March 25, 2025 /PRNewswire/ -- Belay Diagnostics announces its partnership with GenomOncology (GO), a precision medicine software company that provides…
SAN JOSE, Calif., March 25, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics &…
SAN JOSE, Calif., March 25, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics &…
LiveWorld looks to increase its AI investmentCAMPBELL, Calif. and NEW YORK , March 25, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc.…